• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Treatment of general psychovegetative disorders with a single night dose of dipotassium-clorazepate within a multicenter study (author's transl)].

作者信息

Bentel H U, Schoenemeyer J

出版信息

Wien Klin Wochenschr Suppl. 1978;92:1-7.

PMID:31036
Abstract

The therapeutical effect of Tranxilium was studied in an open multicenter study by 66 general practitioners and 26 specialists. 1.027 patients were treated with Tranxilium 20, given in a single dose at night, for a period of three weeks. During this time, the patient's psychic status and functional organic disorders were assessed by means of rating scales. A complete medical assessment followed at the end of the study. States of anxiety, restlessness, depressive mood, irritation and insomnia as well as functional organic disorders improved significantly (p is less than 0.001) already after the first week of treatment. At the end of treatment, with the majority of patients the above symptoms had either completely disappeared or were found only to a small extent. In 85% of the patients, all investigators rated the stabilization and brightening effect on psychic conditions as well as the harmonizing effect on disturbed organic functions as "very good" to "good". In 89% of the patients, the overall therapeutic success was judged as "very good" to "good". The overall tolerance was excellent in 96% of the cases.

摘要

相似文献

1
[Treatment of general psychovegetative disorders with a single night dose of dipotassium-clorazepate within a multicenter study (author's transl)].
Wien Klin Wochenschr Suppl. 1978;92:1-7.
2
[The role of chlorazepate dipotassium (Tranxilium) in the therapy of psychosomatic syndromes (author's transl)].
Med Klin. 1975 Aug 1;70(31):1279-83.
3
Effectiveness of bedtime dosing of benzodiazepines: a placebo-controlled comparison of halazepam and clorazepate.
Clin Ther. 1980;3(3):209-18.
4
Effect of clorazepate on depressed mood in anxious patients.氯氮䓬对焦虑患者抑郁情绪的影响。
J Clin Psychiatry. 1987 Jan;48(1):13-4.
5
[Bromazepam in the treatment of somatized psychogenic disorders (author's transl)].
Wien Klin Wochenschr. 1979 Mar 30;91(7):240-4.
6
[Clobazam (Frisium) in everyday practice. An open six-months' study of its efficacy and tolerance (author's transl)].
MMW Munch Med Wochenschr. 1977 Dec 16;119(50):1623-6.
7
[Comparison of the effectiveness of orally administered clorazepate dipotassium and nordiazepam on preoperative anxiety].口服双钾氯氮卓和去甲西泮对术前焦虑的疗效比较
Anaesthesiol Reanim. 1995;20(6):144-8.
8
Depressive symptoms and intellectual functioning in anxiety patients treated with clorazepate.用氯氮䓬治疗的焦虑症患者的抑郁症状与智力功能
J Clin Psychiatry. 1988 May;49(5):189-92.
9
[The use of chlorazepate dipotassium (Tranxene) in the states of restlessness and agitation].
Psychiatr Pol. 1997 Nov-Dec;31(6):753-60.
10
[Double-blind trial of flunitrazepam in insomnia].
Nouv Presse Med. 1979 Jul 11;8(31):2559-60.